6875.TWO
Price:
$53.6
Market Cap:
$6.92B
Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It is developing L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei City, Taiwan.
Industry
Biotechnology
IPO Date
2022-02-22
Stock Exchange
TWO
Ticker
6875.TWO
According to Pharmosa Biopharm Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.27. This represents a change of -14.07% compared to the average of 16.60 of the last 4 quarters.
The mean historical Current Ratio of Pharmosa Biopharm Inc. over the last ten years is 11.81. The current 14.27 Current Ratio has changed 11.98% with respect to the historical average. Over the past ten years (40 quarters), 6875.TWO's Current Ratio was at its highest in in the September 2024 quarter at 25.20. The Current Ratio was at its lowest in in the September 2022 quarter at 0.
Average
11.81
Median
13.71
Minimum
0
Maximum
24.65
Discovering the peaks and valleys of Pharmosa Biopharm Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 24.65
Minimum Annual Increase = -47.18%
Minimum Annual Current Ratio = 0
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 14.48 | 11.22% |
| 2023 | 13.02 | -47.18% |
| 2022 | 24.65 | 71.29% |
| 2021 | 14.39 | 234.24% |
| 2020 | 4.31 | Infinity% |
The current Current Ratio of Pharmosa Biopharm Inc. (6875.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
17.38
5-year avg
14.17
10-year avg
11.81
Pharmosa Biopharm Inc.’s Current Ratio is greater than TaiGen Biopharmaceuticals Holdings Limited (12.81), greater than Mycenax Biotech Inc. (0.84), greater than OBI Pharma, Inc. (6.54), less than CHO Pharma, Inc. (21.85), greater than Sinphar Pharmaceutical Co.,Ltd. (2.07), greater than Adimmune Corporation (2.00), less than BioGend Therapeutics Co., Ltd. (21.53), greater than Panion & Bf Biotech Inc. (1.32), greater than Savior Lifetec Corporation (8.88), less than Locus Cell Co., Ltd. (0),
| Company | Current Ratio | Market cap |
|---|---|---|
| 12.81 | $7.90B | |
| 0.84 | $6.72B | |
| 6.54 | $7.59B | |
| 21.85 | $6.33B | |
| 2.07 | $5.83B | |
| 2.00 | $8.11B | |
| 21.53 | $4.75B | |
| 1.32 | $5.72B | |
| 8.88 | $5.63B | |
| 0 | $5.81B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmosa Biopharm Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharmosa Biopharm Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Pharmosa Biopharm Inc.'s Current Ratio?
How is the Current Ratio calculated for Pharmosa Biopharm Inc. (6875.TWO)?
What is the highest Current Ratio for Pharmosa Biopharm Inc. (6875.TWO)?
What is the 3-year average Current Ratio for Pharmosa Biopharm Inc. (6875.TWO)?
What is the 5-year average Current Ratio for Pharmosa Biopharm Inc. (6875.TWO)?
How does the current Current Ratio for Pharmosa Biopharm Inc. (6875.TWO) compare to its historical average?